Balance Sheet Mankind Pharma Limited

Stocks

MANKIND

INE634S01028

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:09 10/07/2026 pm IST			5-day change	1st Jan Change
2,525.10 ^INR	-0.27%		-0.14%	+14.96%

07/07	InCred Starts Mankind Pharma at Add with INR2,821 Price Target	MT
02/07	BatX Energies Pvt. Ltd. announced that it has received INR 1,050 million in funding from IvyCap Ventures, Zephyr Management, L.P., JITO Angel Network and other investors	CI

0027.oyYhO8y-Y_FU2Mn7tMC21-ahA30vMKu7HRGzKMZrvmA.-kJkfJTNJYIXnoWD57fXgKLoZCx_Z8_aW1fLRq4a9APMQhBZiYwZySWx_Q

Published financial data: MANKIND PHARMA LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	7.78TCr	8.75TCr	10TCr	12TCr	14TCr
Total Revenues	7.78TCr	8.75TCr	10TCr	12TCr	14TCr
Cost of Goods Sold, Total	2.49TCr	3TCr	3.32TCr	3.66TCr	4.26TCr
Gross Profit	5.29TCr	5.75TCr	7.01TCr	8.55TCr	10TCr
Selling General & Admin Expenses, Total	2.09TCr	2.31TCr	2.9TCr	3.47TCr	4.01TCr
Depreciation & Amortization - (IS)	166.62Cr	325.92Cr	398.25Cr	621.22Cr	886.18Cr
Other Operating Expenses	1.16TCr	1.52TCr	1.56TCr	2.05TCr	2.3TCr
Other Operating Expenses, Total	3.42TCr	4.16TCr	4.86TCr	6.14TCr	7.19TCr
Operating Income	1.88TCr	1.59TCr	2.15TCr	2.41TCr	2.82TCr
Interest Expense, Total	-56Cr	-40Cr	-29Cr	-420.89Cr	-633.4Cr
Interest And Investment Income	13Cr	13Cr	40Cr	68Cr	58Cr
Net Interest Expenses	-43Cr	-28Cr	11Cr	-352.98Cr	-575.35Cr
Income (Loss) On Equity Invest.	14Cr	12Cr	15Cr	12Cr	12Cr
Currency Exchange Gains (Loss)	8.84Cr	10Cr	8.64Cr	20Cr	70Cr
Other Non Operating Income (Expenses)	3.31Cr	54Cr	88Cr	111.47Cr	13Cr
EBT, Excl. Unusual Items	1.86TCr	1.64TCr	2.27TCr	2.2TCr	2.34TCr
Impairment of Goodwill	-	-3.85Cr	-	-	-
Gain (Loss) On Sale Of Investments	112.95Cr	37Cr	129.53Cr	160.84Cr	127.23Cr
Gain (Loss) On Sale Of Assets	-3.74Cr	1.66Cr	48.01L	161.35Cr	-2.31Cr
Asset Writedown	-5.76Cr	-9.71Cr	-9.16Cr	-5.02Cr	-12Cr
Insurance Settlements	1.36Cr	4.31Cr	1.07Cr	97L	3.36Cr
Other Unusual Items	8.53Cr	4.15Cr	2.48Cr	81L	-122.27Cr
EBT, Incl. Unusual Items	1.97TCr	1.67TCr	2.4TCr	2.52TCr	2.33TCr
Income Tax Expense	521.64Cr	361.56Cr	457.59Cr	509.74Cr	394.58Cr
Earnings From Continuing Operations	1.45TCr	1.31TCr	1.94TCr	2.01TCr	1.94TCr
Earnings Of Discontinued Operations	-	-	-	4.53Cr	-
Net Income to Company	1.45TCr	1.31TCr	1.94TCr	2.01TCr	1.94TCr
Minority Interest	-19Cr	-28Cr	-29Cr	-20Cr	-25Cr
Net Income - (IS)	1.43TCr	1.28TCr	1.91TCr	1.99TCr	1.91TCr
Net Income to Common Incl Extra Items	1.43TCr	1.28TCr	1.91TCr	1.99TCr	1.91TCr
Net Income to Common Excl. Extra Items	1.43TCr	1.28TCr	1.91TCr	1.99TCr	1.91TCr
Per Share Items
Net EPS - Basic	35.78	32	47.75	49.28	46.35
Basic EPS - Continuing Operations	35.78	32	47.75	49.17	46.35
Basic Weighted Average Shares Outstanding	40Cr	40Cr	40Cr	40Cr	41Cr
Net EPS - Diluted	35.78	32	47.68	49.19	46.28
Diluted EPS - Continuing Operations	35.78	32	47.68	49.08	46.28
Diluted Weighted Average Shares Outstanding	40Cr	40Cr	40Cr	40Cr	41Cr
Normalized Basic EPS	28.55	24.85	34.77	33.5	34.81
Normalized Diluted EPS	28.55	24.85	34.72	33.44	34.76
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	2.16
Supplemental Items
EBITDA	2.04TCr	1.91TCr	2.54TCr	2.99TCr	3.63TCr
EBITA	1.9TCr	1.74TCr	2.31TCr	2.74TCr	3.37TCr
EBIT	1.88TCr	1.59TCr	2.15TCr	2.41TCr	2.82TCr
EBITDAR	2.06TCr	1.93TCr	2.56TCr	3.02TCr	3.66TCr
Total Revenues (As Reported)	7.98TCr	8.88TCr	11TCr	13TCr	15TCr
Effective Tax Rate - (Ratio)	26.42	21.63	19.07	20.26	16.92
Total Current Taxes	469.03Cr	327.56Cr	492.58Cr	596.04Cr	582.89Cr
Total Deferred Taxes	53Cr	34Cr	-35Cr	-86Cr	-188.31Cr
Normalized Net Income	1.14TCr	995.46Cr	1.39TCr	1.35TCr	1.44TCr
Interest on Long-Term Debt	47.95L	44.92L	78.51L	1.43Cr	5.41Cr
Non-Cash Pension Expense	4.12Cr	5.23Cr	6.56Cr	14Cr	93Cr
Supplemental Operating Expense Items
Advertising Expense	451.57Cr	373.67Cr	603.89Cr	755.36Cr	797.81Cr
Selling and Marketing Expenses	451.57Cr	373.67Cr	603.89Cr	755.36Cr	797.81Cr
Research And Development Expense From Footnotes	-	25Cr	25Cr	25Cr	25Cr
Net Rental Expense, Total	21Cr	20Cr	23Cr	26Cr	31Cr
Imputed Operating Lease Interest Expense	16Cr	12Cr	28Cr	20Cr	21Cr
Imputed Operating Lease Depreciation	4.95Cr	7.94Cr	-4.92Cr	5.84Cr	9.71Cr
Maintenance & Repair Expenses, Total	66Cr	89Cr	111.03Cr	170.53Cr	212.48Cr
Stock-Based Comp., SG&A Exp. (Total)	-	6L	23Cr	27Cr	18Cr
Total Stock-Based Compensation	-	6L	23Cr	27Cr	18Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	302.53Cr	304.82Cr	382.01Cr	407.36Cr	391.69Cr
Short Term Investments	102.31Cr	141.31Cr	746.38Cr	398Cr	278.65Cr
Trading Asset Securities, Total	861.47Cr	1.08TCr	2.26TCr	1.69TCr	1.54TCr
Total Cash And Short Term Investments	1.27TCr	1.52TCr	3.39TCr	2.5TCr	2.21TCr
Accounts Receivable, Total	388.17Cr	576.42Cr	848.28Cr	1.54TCr	1.73TCr
Other Receivables	35Cr	32Cr	44Cr	36Cr	49Cr
Notes Receivable	1.19Cr	1.63Cr	2.86Cr	3.95Cr	4.31Cr
Total Receivables	423.99Cr	610.16Cr	894.96Cr	1.58TCr	1.78TCr
Inventory	1.76TCr	1.5TCr	1.55TCr	2.09TCr	2.14TCr
Prepaid Expenses	136.01Cr	33Cr	60Cr	61Cr	52Cr
Other Current Assets, Total	820.27Cr	664.49Cr	672.92Cr	758.65Cr	767.52Cr
Total Current Assets	4.41TCr	4.33TCr	6.57TCr	6.99TCr	6.95TCr
Gross Property Plant And Equipment	2.97TCr	3.76TCr	4.1TCr	4.38TCr	5.03TCr
Accumulated Depreciation	-582.24Cr	-743.73Cr	-963.39Cr	-1.16TCr	-1.41TCr
Net Property Plant And Equipment	2.39TCr	3.02TCr	3.14TCr	3.21TCr	3.61TCr
Long-term Investments	240.39Cr	357.76Cr	311.06Cr	484.81Cr	451.67Cr
Goodwill	20Cr	20Cr	20Cr	6.49TCr	6.49TCr
Other Intangibles, Total	1.87TCr	1.76TCr	1.66TCr	10TCr	9.64TCr
Loans Receivable Long-Term	3L	-	-	-	-
Deferred Tax Assets Long-Term	39Cr	30Cr	80Cr	107.89Cr	324.7Cr
Other Long-Term Assets, Total	176.97Cr	204.61Cr	181.82Cr	348.41Cr	600.88Cr
Total Assets	9.15TCr	9.72TCr	12TCr	28TCr	28TCr
Liabilities
Accounts Payable, Total	1.08TCr	1.01TCr	1.1TCr	1.13TCr	1.34TCr
Accrued Expenses, Total	259.77Cr	171.02Cr	222.78Cr	781.24Cr	852.09Cr
Short-term Borrowings	805.15Cr	115.02Cr	151.47Cr	2.7TCr	821.48Cr
Current Portion of Long-Term Debt	24Cr	24Cr	20Cr	261.14Cr	2.56TCr
Current Portion of Leases	2.06Cr	2.56Cr	3.42Cr	14Cr	36Cr
Current Income Taxes Payable	15Cr	46Cr	46Cr	18Cr	11Cr
Unearned Revenue Current, Total	19Cr	166.23Cr	185.85Cr	194.03Cr	192.19Cr
Other Current Liabilities	421.37Cr	329.4Cr	387.13Cr	565.58Cr	691.85Cr
Total Current Liabilities	2.62TCr	1.86TCr	2.12TCr	5.66TCr	6.51TCr
Long-Term Debt	49Cr	23Cr	25Cr	5.53TCr	2.82TCr
Long-Term Leases	2.99Cr	5.18Cr	7.71Cr	14Cr	71Cr
Unearned Revenue Non Current	20Cr	25Cr	23Cr	20Cr	30Cr
Pension & Other Post Retirement Benefits	80Cr	98Cr	123.12Cr	155.06Cr	248.65Cr
Deferred Tax Liability Non Current	56Cr	77Cr	89Cr	1.81TCr	1.84TCr
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	2.83TCr	2.09TCr	2.39TCr	13TCr	12TCr
Common Stock, Total	40Cr	40Cr	40Cr	41Cr	41Cr
Additional Paid In Capital	42Cr	42Cr	42Cr	3.01TCr	3.04TCr
Retained Earnings	6.97TCr	8.25TCr	10TCr	12TCr	14TCr
Comprehensive Income and Other	-899.87Cr	-896.9Cr	-875.67Cr	-861.47Cr	-826.12Cr
Total Common Equity	6.16TCr	7.44TCr	9.36TCr	14TCr	16TCr
Minority Interest	161.08Cr	188.07Cr	212.7Cr	235.79Cr	260.71Cr
Total Equity	6.32TCr	7.62TCr	9.58TCr	15TCr	17TCr
Total Liabilities And Equity	9.15TCr	9.72TCr	12TCr	28TCr	28TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	40Cr	40Cr	40Cr	41Cr	41Cr
ECS Total Common Shares Outstanding	40Cr	40Cr	40Cr	41Cr	41Cr
Book Value / Share	153.65	185.61	233.73	347.39	394.85
Tangible Book Value	4.26TCr	5.66TCr	7.68TCr	-2.28TCr	166.6Cr
Tangible Book Value Per Share	106.36	141.21	191.72	-55.35	4.04
Total Debt	883.64Cr	170.37Cr	207.17Cr	8.51TCr	6.31TCr
Net Debt	-382.68Cr	-1.35TCr	-3.18TCr	6.02TCr	4.1TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	81Cr	99Cr	124.03Cr	285.39Cr	255.11Cr
Debt Equivalent Oper. Leases	170.06Cr	163.41Cr	185.7Cr	205.44Cr	245.52Cr
Minority Interest, Total (Incl. Fin. Div)	161.08Cr	188.07Cr	212.7Cr	235.79Cr	260.71Cr
Equity Method Investments, Total	167.74Cr	181.41Cr	189.28Cr	190.9Cr	199.84Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	399.81Cr	417.08Cr	410.76Cr	551.83Cr	628.95Cr
Inventories - Work In Process, Total	94Cr	86Cr	100Cr	186.08Cr	222.63Cr
Inventories - Finished Goods, Total	1.2TCr	919.76Cr	1TCr	1.31TCr	1.24TCr
Inventories - Others	66Cr	76Cr	42Cr	46Cr	55Cr
Land - (BS)	243.48Cr	352.79Cr	352.99Cr	380.09Cr	380.75Cr
Buildings, Total	586.27Cr	1.05TCr	1.25TCr	1.04TCr	1.06TCr
Machinery, Total	1.39TCr	1.74TCr	2.15TCr	2.45TCr	2.63TCr
Full Time Employees	-	18.47T	19.54T	19.62T	20.45T
Accumulated Allowance for Doubtful Accounts (Supple)	11Cr	20Cr	28Cr	61Cr	62Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	1.43TCr	1.28TCr	1.91TCr	1.99TCr	1.91TCr
Depreciation & Amortization - CF	141.4Cr	167.08Cr	235.87Cr	258.93Cr	292.4Cr
Amortization of Goodwill and Intangible Assets - (CF)	20Cr	153.73Cr	153.65Cr	335.07Cr	546.4Cr
Depreciation & Amortization, Total	161.64Cr	320.81Cr	389.52Cr	594Cr	838.8Cr
Amortization of Deferred Charges, Total - (CF)	4.98Cr	5.11Cr	8.73Cr	27Cr	47Cr
(Gain) Loss From Sale Of Asset	3.74Cr	-1.66Cr	-48.01L	-161.35Cr	2.31Cr
(Gain) Loss on Sale of Investments - (CF)	-104.95Cr	-37Cr	-133.53Cr	-160.84Cr	-126.24Cr
Asset Writedown & Restructuring Costs	-2.24Cr	14Cr	9.16Cr	4.35Cr	7.04Cr
Provision for Credit Losses	3.03Cr	1.94Cr	4Cr	-	-
(Income) Loss On Equity Investments - (CF)	-14Cr	-12Cr	-15Cr	-12Cr	-12Cr
Stock-Based Compensation (CF)	-	6L	23Cr	27Cr	18Cr
Provision and Write-off of Bad Debts	12Cr	14Cr	14Cr	14Cr	20Cr
Net Cash From Discontinued Operations	-	-	-	8.45Cr	-
Other Operating Activities, Total	9.12Cr	61Cr	-80Cr	229Cr	307.63Cr
Change In Accounts Receivable	-66Cr	-205.31Cr	-289.91Cr	-123.55Cr	-172.04Cr
Change In Inventories	-576.7Cr	261.78Cr	-55Cr	-220.7Cr	-51Cr
Change In Accounts Payable	419.85Cr	-65Cr	97Cr	-146.04Cr	210.32Cr
Change in Other Net Operating Assets	-363.32Cr	175.28Cr	267.88Cr	343.87Cr	117.31Cr
Cash from Operations	919.78Cr	1.81TCr	2.15TCr	2.41TCr	3.12TCr
Capital Expenditure	-464.86Cr	-789.02Cr	-315.33Cr	-460.79Cr	-625.96Cr
Sale of Property, Plant, and Equipment	3.15Cr	6.05Cr	7.51Cr	12Cr	2.99Cr
Cash Acquisitions	-	-3.83Cr	-	-14TCr	-
Divestitures	-	-	-	562.46Cr	-
Sale (Purchase) of Real Estate properties	-	-	-	7.99Cr	-
Sale (Purchase) of Intangible assets	-1.88TCr	-43Cr	-67Cr	-59Cr	-111.28Cr
Investment in Marketable and Equity Securities, Total	943.04Cr	-236.64Cr	-1.74TCr	901.26Cr	480.14Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-10L	-40.94L	-	-	-
Other Investing Activities, Total	30Cr	13Cr	32Cr	47Cr	58Cr
Cash from Investing	-1.37TCr	-1.05TCr	-2.08TCr	-13TCr	-196.42Cr
Short Term Debt Issued, Total	1.27TCr	1.09TCr	374.61Cr	6.56TCr	3.96TCr
Long-Term Debt Issued, Total	5.86Cr	3.85Cr	26Cr	5.89TCr	16Cr
Total Debt Issued	1.28TCr	1.1TCr	400.7Cr	12TCr	3.98TCr
Short Term Debt Repaid, Total	-645.35Cr	-1.76TCr	-339.81Cr	-4.48TCr	-5.75TCr
Long-Term Debt Repaid, Total	-10Cr	-32Cr	-29Cr	-603.89Cr	-493.38Cr
Total Debt Repaid	-655.78Cr	-1.8TCr	-369.27Cr	-5.08TCr	-6.24TCr
Issuance of Common Stock	-	-	-	2.96TCr	21Cr
Common Dividends Paid	-	-	-	-	-41Cr
Common & Preferred Stock Dividends Paid	-	-	-	-	-41Cr
Other Financing Activities, Total	-18Cr	-42Cr	-26Cr	-98Cr	-669.04Cr
Cash from Financing	604.62Cr	-739.73Cr	5.27Cr	10TCr	-2.95TCr
Foreign Exchange Rate Adjustments	47.79L	2.32Cr	1.17Cr	1.31Cr	16Cr
Miscellaneous Cash Flow Adjustments	1T	-	-	67Cr	-
Net Change in Cash	155.73Cr	22Cr	77Cr	22Cr	-12Cr
Supplemental Items
Cash Interest Paid	18Cr	42Cr	26Cr	98Cr	669.04Cr
Cash Income Tax Paid (Refund)	499.51Cr	323.1Cr	479.53Cr	566.75Cr	592.73Cr
Levered Free Cash Flow	-1.62TCr	711.74Cr	1.21TCr	805.98Cr	1.67TCr
Unlevered Free Cash Flow	-1.59TCr	736.91Cr	1.23TCr	1.07TCr	2.07TCr
Change In Net Working Capital	582.3Cr	-250.32Cr	151.41Cr	563.15Cr	-141.56Cr
Net Debt Issued / Repaid	622.41Cr	-697.8Cr	31Cr	7.37TCr	-2.26TCr

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	15.12	10.52	12.41	7.57	6.31
Return on Total Capital	19.01	13.24	15.3	9.16	7.67
Return On Equity %	25.99	18.79	22.58	16.62	12.45
Return on Common Equity	26.36	18.86	22.77	16.77	12.49
Margin Analysis
Gross Profit Margin %	68.03	65.68	67.87	70.02	70.13
SG&A Margin	26.9	26.43	28.08	28.45	28.1
EBITDA Margin %	26.17	21.77	24.54	24.49	25.42
EBITA Margin %	24.39	19.91	22.31	22.46	23.57
EBIT Margin %	24.13	18.15	20.82	19.72	19.74
Income From Continuing Operations Margin %	18.67	14.97	18.79	16.44	13.57
Net Income Margin %	18.42	14.65	18.51	16.31	13.4
Net Avail. For Common Margin %	18.42	14.65	18.51	16.27	13.4
Normalized Net Income Margin	14.7	11.38	13.48	11.08	10.06
Levered Free Cash Flow Margin	-20.85	8.13	11.75	6.6	11.73
Unlevered Free Cash Flow Margin	-20.4	8.42	11.93	8.76	14.5
Asset Turnover
Asset Turnover	1	0.93	0.95	0.61	0.51
Fixed Assets Turnover	3.55	3.24	3.36	3.84	4.18
Receivables Turnover (Average Receivables)	21.65	18.14	14.51	10.23	8.74
Inventory Turnover (Average Inventory)	1.69	1.84	2.18	2.01	2.01
Short Term Liquidity
Current Ratio	1.68	2.32	3.1	1.23	1.07
Quick Ratio	0.64	1.14	2.02	0.72	0.61
Operating Cash Flow to Current Liabilities	0.35	0.97	1.02	0.43	0.48
Days Sales Outstanding (Average Receivables)	16.86	20.12	25.23	35.68	41.77
Days Outstanding Inventory (Average Inventory)	215.94	198.03	168.19	181.88	181.37
Average Days Payable Outstanding	103.82	138.78	114.45	83.02	104.66
Cash Conversion Cycle (Average Days)	128.98	79.37	78.97	134.54	118.48
Long Term Solvency
Total Debt/Equity	13.99	2.23	2.16	58.42	38.11
Total Debt / Total Capital	12.27	2.19	2.12	36.88	27.59
LT Debt/Equity	0.83	0.37	0.34	38.03	17.47
Long-Term Debt / Total Capital	0.72	0.36	0.33	24	12.65
Total Liabilities / Total Assets	30.95	21.53	19.96	47.52	41.02
EBIT / Interest Expense	33.66	39.44	75.24	5.72	4.45
EBITDA / Interest Expense	36.56	47.4	88.86	7.13	5.78
(EBITDA - Capex) / Interest Expense	28.22	27.81	77.83	6.04	4.79
Total Debt / EBITDA	0.43	0.09	0.08	2.84	1.73
Net Debt / EBITDA	-0.19	-0.71	-1.25	2	1.12
Total Debt / (EBITDA - Capex)	0.56	0.15	0.09	3.35	2.08
Net Debt / (EBITDA - Capex)	-0.24	-1.21	-1.43	2.37	1.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	25.22	12.44	18.12	18.98	16.96
Gross Profit, 1 Yr. Growth %	21.21	8.55	22.06	22.9	17.25
EBITDA, 1 Yr. Growth %	19.51	-4.31	33.15	18.87	17.44
EBITA, 1 Yr. Growth %	18.55	-5.96	32.34	19.02	18.36
EBIT, 1 Yr. Growth %	18.06	-13.32	35.48	11.95	12.39
Earnings From Cont. Operations, 1 Yr. Growth %	12.37	-9.86	48.26	3.39	-3.41
Net Income, 1 Yr. Growth %	13.28	-10.58	49.23	4.08	-3.92
Normalized Net Income, 1 Yr. Growth %	15.62	-12.97	39.93	-2.79	6.17
Diluted EPS Before Extra, 1 Yr. Growth %	13.27	-10.57	49	2.98	-5.7
Accounts Receivable, 1 Yr. Growth %	17.41	48.5	47.16	81.35	12.43
Inventory, 1 Yr. Growth %	48.73	-14.87	3.67	34.78	2.42
Net Property, Plant and Equip., 1 Yr. Growth %	19.98	26.26	4.03	2.4	12.46
Total Assets, 1 Yr. Growth %	43.55	6.21	23.14	132.04	1.15
Tangible Book Value, 1 Yr. Growth %	-9.02	32.77	35.77	-129.74	-107.29
Common Equity, 1 Yr. Growth %	30.35	20.8	25.93	53.07	13.73
Cash From Operations, 1 Yr. Growth %	-19.12	97.15	18.7	12.12	29.33
Capital Expenditures, 1 Yr. Growth %	52.21	69.73	-60.03	46.13	35.84
Levered Free Cash Flow, 1 Yr. Growth %	-379.11	-143.45	70.67	-32.52	92.68
Unlevered Free Cash Flow, 1 Yr. Growth %	-367.56	-145.97	67.26	-11.78	82.88
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.12	18.66	15.24	18.12	17.96
Gross Profit, 2 Yr. CAGR %	15.77	14.71	15.11	21.96	19.99
EBITDA, 2 Yr. CAGR %	14.05	5.74	12.87	25.27	20.14
EBITA, 2 Yr. CAGR %	13.39	4.32	11.56	25.46	20.86
EBIT, 2 Yr. CAGR %	12.99	-0.06	8.37	23.11	14.5
Earnings From Cont. Operations, 2 Yr. CAGR %	17.29	0.64	15.6	23.78	-0.07
Net Income, 2 Yr. CAGR %	17.95	0.65	15.52	24.63	0
Normalized Net Income, 2 Yr. CAGR %	12.72	0.31	10.36	16.59	1.59
Diluted EPS Before Extra, 2 Yr. CAGR %	17.95	0.65	15.44	23.85	-1.46
Accounts Receivable, 2 Yr. CAGR %	-14.51	32.04	47.83	63.36	42.79
Inventory, 2 Yr. CAGR %	39.92	12.52	-6.06	18.2	17.49
Net Property, Plant and Equip., 2 Yr. CAGR %	13.21	23.08	14.61	3.21	7.31
Total Assets, 2 Yr. CAGR %	34.28	23.47	14.36	69.03	53.2
Tangible Book Value, 2 Yr. CAGR %	11.31	9.91	34.26	-36.46	-85.27
Common Equity, 2 Yr. CAGR %	32.89	25.48	23.34	38.84	31.94
Cash From Operations, 2 Yr. CAGR %	-7.38	26.27	52.98	15.37	20.42
Capital Expenditures, 2 Yr. CAGR %	42.8	60.73	-17.64	-23.58	40.89
Levered Free Cash Flow, 2 Yr. CAGR %	46.83	10.65	-13.88	6.42	18.42
Unlevered Free Cash Flow, 2 Yr. CAGR %	43.96	11.44	-12.31	20.45	30.72
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.04	14.22	18.48	16.19	17.73
Gross Profit, 3 Yr. CAGR %	17.92	13.31	17.11	17.32	20.34
EBITDA, 3 Yr. CAGR %	29.59	6.77	14.19	14.51	23.97
EBITA, 3 Yr. CAGR %	29.69	5.68	12.93	13.97	24.55
EBIT, 3 Yr. CAGR %	29.26	2.6	10.6	9.52	21.08
Earnings From Cont. Operations, 3 Yr. CAGR %	33.51	7.44	14.52	11.36	13.96
Net Income, 3 Yr. CAGR %	35.32	7.55	14.77	11.57	14.28
Normalized Net Income, 3 Yr. CAGR %	32.07	3.41	12.08	5.76	13.01
Diluted EPS Before Extra, 3 Yr. CAGR %	35.32	7.55	14.71	11.11	13.09
Accounts Receivable, 3 Yr. CAGR %	20.8	2.77	36.9	58.25	44.23
Inventory, 3 Yr. CAGR %	28.95	18.56	9.49	5.95	12.69
Net Property, Plant and Equip., 3 Yr. CAGR %	12.49	17.4	16.37	10.38	6.21
Total Assets, 3 Yr. CAGR %	30.54	24.18	23.36	44.78	42.44
Tangible Book Value, 3 Yr. CAGR %	15.37	18.05	17.93	-18.77	-69.12
Common Equity, 3 Yr. CAGR %	29.67	28.73	25.63	32.54	29.91
Cash From Operations, 3 Yr. CAGR %	15.28	19.14	23.7	37.93	19.85
Capital Expenditures, 3 Yr. CAGR %	16.02	51.26	1.07	-0.29	-7.43
Levered Free Cash Flow, 3 Yr. CAGR %	-	-1.84	27.84	-21.05	33.01
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-1.29	27.59	-12.63	41.11
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	15.72	15.76	18.1
Gross Profit, 5 Yr. CAGR %	-	-	16.79	16.7	18.05
EBITDA, 5 Yr. CAGR %	-	-	22.08	13.82	16.33
EBITA, 5 Yr. CAGR %	-	-	21.52	13.19	16.02
EBIT, 5 Yr. CAGR %	-	-	19.87	10.36	12.13
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	26.04	13.7	8.43
Net Income, 5 Yr. CAGR %	-	-	27.02	14.08	8.62
Normalized Net Income, 5 Yr. CAGR %	-	-	22.91	8.49	7.75
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	26.99	13.8	7.94
Accounts Receivable, 5 Yr. CAGR %	-	-	30.96	23.7	39.23
Inventory, 5 Yr. CAGR %	-	-	13.6	18.42	12.62
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	13.33	11.5	12.66
Total Assets, 5 Yr. CAGR %	-	-	23.81	40.48	34.53
Tangible Book Value, 5 Yr. CAGR %	-	-	22.58	-7.86	-48.69
Common Equity, 5 Yr. CAGR %	-	-	27.1	32.68	28.12
Cash From Operations, 5 Yr. CAGR %	-	-	29.09	17.62	22.38
Capital Expenditures, 5 Yr. CAGR %	-	-	1.16	15.11	15.43
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	1.38	23.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	6.89	28.4